Evidence map›Paper›PMID 39355119›Full record

ArticleFrontiers in cell and developmental biology2024

Spatiotemporal regulation of MELK during mitosis.

Sreemita Majumdar, Song-Tao Liu

Abstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sreemita MajumdarDepartment of Biological Sciences, University of Toledo, Toledo, OH, United States.
Song-Tao LiuDepartment of Biological Sciences, University of Toledo, Toledo, OH, United States.

Funding

MTFR2 in the control of mitochondrial dynamics and mitotic spindle integrityR15GM147878 · NIGMS · UNIVERSITY OF TOLEDO · PI LIU, SONG-TAO · 2023 to 2024
$591k
Understanding and targeting MELK overexpression in breast cancer cellsR15CA238894 · NCI · UNIVERSITY OF TOLEDO · PI LIU, SONG-TAO · 2020 to 2020
$468k
NCI NIH HHS R15 CA238894NIGMS NIH HHS R15 GM147878
6 · The paper itself

Abstract

Maternal Embryonic Leucine Zipper Kinase (MELK) has been studied intensively in recent years due to its overexpression in multiple cancers. However, the cell biology of MELK remains less characterized despite its well-documented association with mitosis. Here we report a distinctive pattern of human MELK that translocates from the cytoplasm to cell cortex within 3 min of anaphase onset. The cortex association lasts about 30 min till telophase. The spatiotemporal specific localization of MELK depends on the interaction between its Threonine-Proline (TP) rich domain and kinase associated 1 (KA1) domain, which is regulated by CDK1 kinase and PP4 protein phosphatase. KA1 domains are known to regulate kinase activities through various intramolecular interactions. Our results revealed a new role for KA1 domain to control subcellular localization of a protein kinase.

Indexed as

anaphaseCdk1cell cortexKA1 domainMELKPP4

Identifiers

PMID39355119
PMCPMC11443572

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.